SCHEMBL3309543

SCHEMBL3309543

CCCCCCn1cc[n+](CC)c1C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.66
EEF2K O00418 2/20 0.66
EEF2 P13639 2/20 0.66
MEN1 O00255 2/20 0.66
PLK4 O00444 1/20 0.66
JAK2 O60674 1/20 0.66
EGFR P00533 1/20 0.66
TYK2 P29597 1/20 0.66
FLT3 P36888 1/20 0.66
BLM P54132 1/20 0.66
ITK Q08881 1/20 0.66
PIM2 Q9P1W9 1/20 0.66
CA1 P00915 6/20 0.62
CA2 P00918 6/20 0.62
NPC1 O15118 6/20 0.39
RAB9A P51151 6/20 0.39
HTT P42858 6/20 0.39
MAPK1 P28482 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5306601 1.00 KMT2A (0.66) KMT2AEEF2KEEF2MEN1PLK4
SCHEMBL5301652 1.00 KMT2A (0.66) KMT2AEEF2KEEF2MEN1PLK4
SCHEMBL5814529 1.00 KMT2A (0.66) KMT2AEEF2KEEF2MEN1PLK4
SCHEMBL5304754 1.00 KMT2A (0.66) KMT2AEEF2KEEF2MEN1PLK4
SCHEMBL5289166 1.00 KMT2A (0.66) KMT2AEEF2KEEF2MEN1PLK4
SCHEMBL5287856 1.00 KMT2A (0.66) KMT2AEEF2KEEF2MEN1PLK4
SCHEMBL5288796 1.00 KMT2A (0.66) KMT2AEEF2KEEF2MEN1PLK4
SCHEMBL5283716 1.00 KMT2A (0.66) KMT2AEEF2KEEF2MEN1PLK4
SCHEMBL5287729 1.00 KMT2A (0.66) KMT2AEEF2KEEF2MEN1PLK4
SCHEMBL5297332 1.00 KMT2A (0.66) KMT2AEEF2KEEF2MEN1PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118290346-A Method for producing amide compound, and amide compound 广荣化学株式会社 2024-07-05 CN disclosed
CN-112703184-B Method for producing amide compound, and amide compound 广荣化学株式会社 2024-06-11 CN disclosed
US-20230378459-A1 SECONDARY BATTERY, ELECTRONIC DEVICE, AND VEHICLE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-11-23 US disclosed
US-20230327207-A1 Storage Battery, Battery Control Unit, and Electronic Device SEMICONDUCTOR ENERGY LAB (JP) 2023-10-12 US disclosed
US-20230231199-A1 SECONDARY BATTERY AND VEHICLE INCLUDING SECONDARY BATTERY SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-07-20 US disclosed
US-20200280101-A1 STORAGE BATTERY, BATTERY CONTROL UNIT, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LAB (JP) 2020-09-03 US disclosed
US-10658701-B2 Storage battery, battery control unit, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-05-19 US disclosed
US-20170237127-A1 ELECTRODE, MANUFACTURING METHOD THEREOF, NEGATIVE ELECTRODE, MANUFACTURING METHOD THEREOF, POWER STORAGE DEVICE, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-08-17 US disclosed
US-20170222265-A1 STORAGE BATTERY, BATTERY CONTROL UNIT, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-08-03 US disclosed
EP-2958181-B1 NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEM CORP (JP) 2017-06-14 EP disclosed
US-8673489-B2 Nonaqueous electrolytic solution and nonaqeuous-electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2014-03-18 US disclosed
EP-2166611-B1 NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH THE NONAQUEOUS ELECTROLYTE MITSUBISHI CHEM CORP (JP) 2013-12-25 EP disclosed
US-20130280622-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2013-10-24 US disclosed
EP-2535976-A1 NONAQUEOUS ELECTROLYTE SOLUTION, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2012-12-19 EP disclosed
US-20120308881-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQEUOUS-ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2012-12-06 US disclosed
US-20120264010-A1 NONAQUEOUS ELECTROLYTES AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERIES EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2012-10-18 US disclosed
US-20100099031-A1 NONAQUEOUS ELECTROLYTES AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERIES EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2010-04-22 US disclosed
EP-2166611-A1 NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH THE NONAQUEOUS ELECTROLYTE Mitsubishi Chemical Corporation (JP) 2010-03-24 EP disclosed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO disclosed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230378459-A1 SECONDARY BATTERY, ELECTRONIC DEVICE, AND VEHICLE VDAC3, VDAC2, SCO2 KMT2A 1910/4885EEF2K 3839/4885EEF2 2369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.